Press Releases April 22, 2026 05:00 AM

Fortuna to release first quarter 2026 financial results on May 6, 2026; Conference call at 12 p.m. Eastern time on May 7, 2026

Fortuna Mining Corp. schedules Q1 2026 earnings release and conference call for early May 2026

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
FSM

Fortuna Mining Corp., a Canadian precious metals miner listed on the NYSE and TSX, announced it will release its Q1 2026 financial results on May 6, 2026, after market close. The company will hold a conference call on May 7, 2026, to discuss operational and financial performance, inviting analysts, investors, and media to participate. Fortuna operates three mines and exploration activities across Latin America and West Africa, focusing on sustainable gold and silver production.

Fortuna to release first quarter 2026 financial results on May 6, 2026; Conference call at 12 p.m. Eastern time on May 7, 2026
FSM
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Fortuna Mining Corp. to release Q1 2026 financial statements and MD&A on May 6, 2026, after market close.
  • Conference call scheduled for May 7, 2026, with senior management presenting operational and financial results.
  • Company operates three mines and multiple exploration projects in Latin America and West Africa with emphasis on sustainability and environmental stewardship.

VANCOUVER, British Columbia, April 22, 2026 (GLOBE NEWSWIRE) -- Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) announces that it will release its financial statements and MD&A for the first quarter of 2026 on Wednesday, May 6, 2026, after market close.

A conference call to discuss the financial and operational results will be held on Thursday, May 7, 2026, at 9:00 a.m. Pacific time | 12:00 p.m. Eastern time. Hosting the call will be Jorge A. Ganoza, President and CEO, Luis D. Ganoza, Chief Financial Officer, David Whittle, Chief Operating Officer - West Africa, and Cesar Velasco, Chief Operating Officer - Latin America.

Shareholders, analysts, media and interested investors are invited to listen to the live conference call by logging onto the webcast at https://www.webcaster5.com/Webcast/Page/1696/53929 or over the phone by dialing in just prior to the starting time.

Conference call details:

Date: Thursday, May 7, 2026
Time: 9:00 a.m. Pacific time | 12:00 p.m. Eastern time

Dial in number (Toll Free): +1.888.506.0062
Dial in number (International): +1.973.528.0011
Access code: 788835

Replay number (Toll Free): +1.877.481.4010
Replay number (International): +1.919.882.2331
Replay passcode: 53929

Playback of the earnings call will be available until Thursday, May 21, 2026. Playback of the webcast will be available until Friday, May 7, 2027. In addition, a transcript of the call will be archived on the Company’s website.

About Fortuna Mining Corp.

Fortuna Mining Corp. is a Canadian precious metals mining company with three operating mines and exploration activities in Argentina, Côte d’Ivoire, Guinea, Guyana, Mexico, and Peru, as well as the Diamba Sud Gold Project located in Senegal. Sustainability is at the core of our operations and stakeholder relationships. We produce gold and silver while creating long-term shared value through efficient production, environmental stewardship, and social responsibility. For more information, please visit our website.

ON BEHALF OF THE BOARD

Jorge A. Ganoza
President, CEO, and Director
Fortuna Mining Corp.

Investor Relations:

Carlos Baca | [email protected] | fortunamining.com | X | LinkedIn | YouTube | Instagram | TikTok

A PDF accompanying this announcement is available at: http://ml.globenewswire.com/Resource/Download/20839324-7295-4826-b9be-4d137002f953


Risks

  • Operational risks in mining activities across multiple countries with varying geopolitical and regulatory environments, including Latin America and West Africa.
  • Commodity price volatility affecting gold and silver markets which could impact financial results.
  • Possible operational disruptions or delays impacting production and exploration timelines.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026